SYSTEMATICALLY INDIVIDUALIZING TOBRAMYCIN DOSAGE REGIMENS

被引:19
作者
CIPOLLE, RJ [1 ]
SEIFERT, RD [1 ]
ZASKE, DE [1 ]
STRATE, RG [1 ]
机构
[1] UNIV MINNESOTA,SCH MED,ST PAUL,MN 55101
关键词
D O I
10.1002/j.1552-4604.1980.tb01672.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:570 / 580
页数:11
相关论文
共 29 条
[1]  
ANDERSON AC, 1976, ARCH INTERN MED, V136, P785
[2]   WHY MONITOR SERUM LEVELS OF GENTAMICIN [J].
BARZA, M ;
LAUERMANN, M .
CLINICAL PHARMACOKINETICS, 1978, 3 (03) :202-215
[3]  
BENDUSH SL, 1976, J INFECT DIS S, V135, pS219
[4]  
BURGER LM, 1973, AM J MED SCI, V265, P135, DOI 10.1097/00000441-197302000-00004
[5]  
CUTLER RE, 1972, J AMER MED ASSOC, V219, P1037, DOI 10.1001/jama.219.8.1037
[6]   GENTAMICIN BLOOD-LEVELS - GUIDE TO NEPHROTOXICITY [J].
DAHLGREN, JG ;
ANDERSON, ET ;
HEWITT, WL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (01) :58-62
[7]   TOBRAMYCIN - IN-VITRO ACTIVITY AND COMPARISON WITH KANAMYCIN AND GENTAMICIN [J].
DELBENE, VE ;
FARRAR, WE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1972, 1 (04) :340-&
[8]   PHARMACOKINETICS AND OTOTOXICITY OF GENTAMICIN, TOBRAMYCIN, AND AMIKACIN [J].
FEDERSPIL, P ;
SCHATZLE, W ;
TIESLER, E .
JOURNAL OF INFECTIOUS DISEASES, 1976, 134 :S200-S205
[9]   RAPID INTRAVENOUS-INJECTION OF TOBRAMYCIN - SUGGESTED DOSAGE SCHEDULE AND CONCENTRATIONS IN SERUM [J].
GILLETT, AP ;
FALK, RH ;
ANDREWS, J ;
WISE, R ;
MELIKIAN, V .
JOURNAL OF INFECTIOUS DISEASES, 1976, 134 :S110-S113
[10]  
HIGGENS CE, 1968, ANTIMICROB AGENTS CH, P324